Eli Lilly Corp. buy Guggenheim
Start price
16.10.25
/
50%
€710.00
Target price
16.10.26
€812.06
Performance (%)
29.27%
Price
13:57
€917.80
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 29.27%. This prediction currently runs until 16.10.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 0.197% | 0.197% |
| iShares Core DAX® | 0.323% | 2.208% |
| iShares Nasdaq 100 | 0.145% | -0.987% |
| iShares Nikkei 225® | 0.091% | -1.421% |
| iShares S&P 500 | 0.371% | -0.469% |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $948.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-28.93%
17.08.25
17.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-6.30%
06.08.25
06.08.25